Artem Smirnov
Post-doctoral Fellow
I received my BSc and MSc in biotechnology from the Institute of Technology, St. Petersburg, Russia, where I worked under supervision of Prof Nick A Barlev. My theses were focused on the generation of test-systems to screen for inhibitors of the p53/Mdm2 interaction. After this, I moved to Gerry Melino’s lab at the University of Rome “Tor Vergata”, Italy. There I got my PhD working with Prof Eleonora Candi. The major topic of our research was the investigation of the role of p63 in regulation of keratinocyte differentiation and proliferation, as well as its involvement in epithelial cancer. In 2019 I started my postdoc in Xin Lu’s lab in Oxford where I work on the re-activation of EBV in epithelial cancer.
Recent publications
-
The p63 C-terminus is essential for murine oocyte integrity
Journal article
Lena AM. et al, (2021), Nature Communications, 12
-
Long non‐coding RNA uc.291 controls epithelial differentiation by interfering with the ACTL6A/BAF complex
Journal article
Panatta E. et al, (2020), EMBO reports, 21
-
Transglutaminase 3 Reduces the Severity of Psoriasis in Imiquimod-Treated Mouse Skin
Journal article
Piro M. et al, (2020), International Journal of Molecular Sciences, 21, 1566 - 1566
-
ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
Journal article
Nicolai S. et al, (2020), Molecular Oncology, 14, 294 - 308
-
p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
Journal article
Smirnov A. et al, (2019), International Journal of Molecular Sciences, 20, 5781 - 5781